Increasing evidence from prospective studies have implicated
|
|
- Darcy Gilmore
- 5 years ago
- Views:
Transcription
1 Phobic Anxiety and Risk of Coronary Heart Disease and Sudden Cardiac Death Among Women Christine M. Albert, MD, MPH; Claudia U. Chae, MD, MPH; Kathryn M. Rexrode, MD, MPH; JoAnn E. Manson, MD, DPH; Ichiro Kawachi, MD, PhD Background High levels of phobic anxiety have been associated with elevated risks of coronary heart disease (CHD) death and sudden cardiac death (SCD) among men. To the best of our knowledge, no studies have looked at this association among women. Anxiety may influence CHD mortality by increasing the risk of ventricular arrhythmia and SCD. Methods and Results We prospectively examined the relationship between phobic anxiety, as measured by the Crown-Crisp index (CCI), and CHD among women participating in the Nurses Health Study. Among women with no history of cardiovascular disease or cancer in 1988, 97 SCDs, 267 CHD deaths, and 930 nonfatal myocardial infarctions (MI) were documented over 12 years of follow-up. A higher score on the CCI was associated with an increased risk of SCD and fatal CHD but not of nonfatal MI in age-adjusted (P, trend 0.008) and in multivariable models excluding possible biological intermediaries (P, trend 0.03). Multivariable adjustment appeared to attenuate the relations; women who scored 4 or greater on the CCI were at a 1.59-fold (95% CI, 0.97 to 2.60) marginally increased risk of SCD and a 1.31-fold (95% CI, 0.97 to 1.75) marginally increased risk of fatal CHD compared with those who scored 0 or 1. After control for possible intermediaries (hypertension, diabetes, and elevated cholesterol), a trend toward an increased risk persisted for SCD (P 0.06). Conclusions These prospective data suggest that high levels of phobic anxiety are associated with an increased risk of fatal CHD, particularly from SCD. Some but not all of this risk can be accounted for by CHD risk factors associated with phobic anxiety. (Circulation. 2005;111: ) Key Words: death, sudden women arrhythmia stress Increasing evidence from prospective studies have implicated negative emotions anxiety, anger/hostility, and depression as risk factors for the incidence of coronary heart disease (CHD). 1,2 Several mechanisms have been put forward to explain this finding, including the association of negative emotions with deleterious health behaviors (smoking, poor diet, sedentarism), in addition to the potential direct effects of emotional stress on progression of atherosclerosis as well as lowering of thresholds for ventricular arrhythmia and sudden cardiac death (SCD). 2 In several studies, patients with phobic anxiety or panic disorder appeared to have an increased risk of CHD. 3 In 2 prospective cohort studies involving men, 4,5 high levels of phobic anxiety, as measured by a score of 4 or greater on the Crown-Crisp index, were associated with an elevated risk of CHD death but not nonfatal myocardial infarction (MI). In one of these studies, the Health Professionals Follow-Up Study, 5 the excess risk was confined to sudden rather than nonsudden CHD death. Similar results were found in the Normative Aging Study by use of another measure of chronic anxiety. 6 Although the prevalence of anxiety 7 and phobic disorders 8 is known to be twice as high among women, little is currently known about the relationship between phobic anxiety and CHD and/or SCD among women. In the present study of women free of cardiovascular disease (CVD) and cancer in 1988, we prospectively examined whether symptoms of phobic anxiety, as measured by the Crown- Crisp index, were associated with subsequent CHD outcomes, particularly SCD and fatal CHD, over 12 years of follow-up. Methods The Nurses Health Study Cohort The NHS began in 1976, when registered nurses, 30 to 55 years of age, completed a questionnaire about their medical history, CHD risk factors, menopausal status, and lifestyle factors. The cohort has been followed up every 2 years with mailed question- Received July 15, 2004; accepted December 7, From the Division of Preventive Medicine (C.M.A., C.U.C., K.M.R., J.E.M.) and Channing Laboratory (J.E.M., I.K.), Department of Medicine, Brigham and Women s Hospital and Harvard Medical School; the Cardiology Division (C.M.A., C.U.C.), Department of Medicine, Massachusetts General Hospital and Harvard Medical School; and the Departments of Epidemiology (J.E.M.) and Society, Human Development, and Health (I.K.), Harvard School of Public Health, Boston, Mass. Correspondence to Dr Christine Albert, Division of Preventive Medicine, Brigham and Women s Hospital, 900 Commonwealth Ave East, Boston, MA calbert@partners.org 2005 American Heart Association, Inc. Circulation is available at DOI: /01.CIR D 480
2 Albert et al Phobic Anxiety and Risk of CHD and SCD in Women 481 naires that update exposure information and inquire about newly diagnosed medical illnesses. Population for Analysis As part of the 1988 questionnaire, all participants were asked to complete the phobic anxiety scale of the Crown-Crisp experimental index. These questions were included specifically to address the hypothesis that phobic anxiety is a risk factor for SCD and CHD. Because a previous or perceived diagnosis of CVD or cancer may influence the responses to certain items on the Crown-Crisp index (eg, Do you find yourself worrying about getting some incurable illness ), we excluded from the analyses women who reported nonfatal CVD end points (angina, MI, coronary revascularization, or stroke) or cancer (except nonmelanoma skin cancer) before or at the time of the 1988 questionnaire. Of these women, returned the 1988 questionnaire, and completed at least part of the Crown-Crisp index. Of these women, completed at least 6 of 8 questions and were included in the analysis. Assessment of Phobic Anxiety: The Crown-Crisp Index The Crown-Crisp phobia index measures common symptoms of phobic anxiety and has been validated in psychiatric outpatient clinic settings and found to discriminate patients with anxiety disorders and agoraphobia from healthy controls. 9,10 It is a standardized, self-rating inventory of 8 questions with 2 to 3 levels of possible responses to each question, allowing scores ranging from 0 to 16 (with higher scores given to higher levels of phobic anxiety). 9,10 The individual questions and response options are outlined in Table 4. For those with missing data on 1 or 2 questions (n 4148), the total score was divided by the fraction of questions answered and then rounded to the nearest whole number. In keeping with previous studies in health professionals that have used the Crown-Crisp index, 5 we categorized the total score into the following categories: 0 or 1 (reference category), 2, 3, and 4 or higher (highest levels of phobic anxiety). These categories also separated the population into approximate quartiles, as was done in other studies. 4 End Point Ascertainment and Definitions The study end points comprised incident cases of nonfatal MI, fatal CHD, and SCD occurring after the return of the 1988 questionnaire and before June 1, All nurses who reported having a nonfatal MI were asked for permission to review medical records. Medical records were reviewed by physicians who were blinded to exposure status. The follow-up rate for nonfatal events was 98% of the total potential person-years. Myocardial infarction was confirmed by use of World Health Organization criteria: symptoms plus either diagnostic ECG changes or elevated cardiac enzymes. 11 Infarctions that required hospital admission and for which confirmatory information was obtained by interview or letter, but for which no medical records were available, were designated as probable. Analyses including or excluding these events yielded similar results, so we present analyses including these events. Most deaths are reported by next of kin or postal authorities. In addition, at the completion of each mailing cycle, the National Death Index is searched for names of nonrespondents to the questionnaire. Death follow-up is 98% complete. Death certificates are obtained from state vital statistics departments to confirm deaths, and permission to obtain further information from medical records or verbal reports is requested from family members. Deaths are then confirmed for a cardiovascular cause by physician review of medical records. The next of kin is interviewed regarding the circumstances surrounding the death if not adequately documented in the medical record. Fatal CHD was confirmed by hospital records or autopsy or if CHD was listed as the cause of death on the death certificate along with evidence of previous coronary disease and CHD was the most plausible cause of death. We designated as presumed CHD (24% of fatal cases) those in which CHD was the underlying cause on the death certificate but where no medical records surrounding the death were available. The specific details regarding the classification of SCD are described in detail elsewhere. 12 In brief, a cardiac death was considered sudden if the death and/or cardiac arrest that precipitated the terminal event occurred within 1 hour of symptom onset. To increase our specificity for arrhythmic death, we excluded anyone who had evidence of collapse of the circulation (hypotension, exacerbation of congestive heart failure, and/or altered mental status) before the disappearance of the pulse. 13 Statistical Analysis Age-adjusted means or proportions of cardiovascular risk factors were computed across the 4 categories of the Crown-Crisp index. The significance of associations was tested by use of the Mantel- Haenszel 2 test for trend for categorical variables and linear regression for continuous variables. As a test of internal validity of the Crown-Crisp index, we also examined the association between scores on the Crown-Crisp index in 1988 and reported use of anti-anxiety medications in 2000, the first year in which detailed information on these drugs was collected. Cox proportional-hazards models were then used to compute ageand multivariable-adjusted relative risks of SCD, fatal CHD, and nonfatal MI across the 4 categories of the Crown-Crisp index and age-adjusted relative risks associated with responses to individual items on the Crown-Crisp index. For each woman, person-months of follow-up were calculated from the date of return of the 1988 questionnaire to the date of the first end point or death or to June 1, 2000, whichever came first. Two multivariable models were performed (please see legend of Table 2 for the list of variables included in the models). The first multivariable model simultaneously controlled for all CHD risk factors except for those that theoretically might be in the causal pathway (hypertension, diabetes, and elevated cholesterol). The second multivariable model also included these covariates. If information on covariates was missing, then persontime was assigned to a missing category for that covariate. In secondary models, we updated the information on CHD risk factor status over the 12 years of follow-up to determine how much of the effect could be explained by changes in CHD risk factors over the course of the study. If information was missing during a follow-up period, then person-time was assigned to a missing category for that time period. Tests for trend were performed by assigning the median value for each category of the Crown-Crisp index and then modeling this as a continuous variable in separate Cox proportional-hazards models. In addition, we tested for deviation from linearity by comparing models containing the 4 categories of the Crown-Crisp index with those containing a linear term for these categories in a likelihood-ratio test with 2 degrees of freedom. We also explored whether the observed associations were modified by age or were proportional over the follow-up period by adding cross-product terms composed of the Crown-Crisp trend variable with either age or the logarithm of follow-up time into the full multivariable model. Statistical analysis was performed by use of SAS statistical software (SAS Institute Inc), Version 8.2. Results Among women who were free of CVD at baseline in 1988, 27.7%, or the approximate top quartile, scored 4 or greater on the Crown-Crisp index. Scores ranged from 0 to 14 (out of a possible maximum score of 16; see Figure 1 for distribution of scores). Scores on the Crown-Crisp index were associated with several CHD risk factors (Table 1). Women with higher scores were more likely to have a history of diabetes, hypercholesterolemia, or hypertension. They were also more likely to be heavy smokers or obese (body mass index of 30 kg/m 2 ) and were less physically active. In addition, women with higher scores on the Crown-Crisp index in 1988 were more likely to subsequently report regular use of minor tranquilizers (eg, Valium, Xanax, Ativan,
3 482 Circulation February 1, 2005 Figure 1. Distribution of responses to Crown-Crisp index among women free of CVD in Librium) in 2000 (P 0.001). Women who scored 4 or greater on the Crown-Crisp index were 2.7 (95% CI, 2.5 to 3.0) times more likely to report minor tranquilizer use compared with women who scored 0 or 1. During 12 years of follow-up, a total of 930 nonfatal MIs, 97 SCDs, and 267 total CHD deaths occurred among these TABLE 1. Relationship of Crown-Crisp Index Score to Coronary Heart Disease Risk Factors* Among Women Free of Cardiovascular Disease at Baseline in 1988 Crown-Crisp Index Score Variable 0or No. of women (total N ) Age, y (mean) Smoking, % Past Current 1 14 cigarettes/d Current cigarettes/d Current 25 cigarettes/d Reported diagnosis of Diabetes, % High cholesterol, % Hypertension, % Body mass index, mean Parental history of MI before age y, % Alcohol intake, 3 /wk, % Aspirin use, 7 /wk, % Physical activity, total Mets/wk, mean Postmenopausal hormone use, current, % Vitamin supplement use Vitamin E, % Multivitamin, % *Standardized for age to the total cohort. Information ascertained on the 1988 questionnaire. P P women (Table 2). In age-adjusted models, scores on the Crown-Crisp index were directly related to fatal CHD (P, trend 0.001) and to SCD (P 0.008). These relationships were attenuated, but persisted, after control for smoking status, body mass index, alcohol intake, menopausal status, postmenopausal hormone use, parental history of myocardial infarction, and aspirin and Valium use (Table 2, multivariable model 1). With further control for diabetes, hypertension, and hypercholesterolemia, the relationship for fatal CHD was further attenuated, and the P for trend over the 4 categories of the Crown-Crisp index became nonsignificant (Table 2, multivariable model 2). However, even after control for these potential biological mediators in the causal pathway, a trend toward an increased risk persisted for SCD (P 0.06). When we updated the information on CHD risk factor status over the 12 years of follow-up to determine how much of the effect could be explained by changes in CHD risk factors over the course of the study, the relationship with fatal CHD was almost completely attenuated (P, trend 0.30; RR comparing extreme categories 1.10 [95% CI, 0.82 to 1.47]), whereas a marginal trend toward an increased risk of SCD persisted (P, trend 0.08; RR comparing extreme categories 1.42 [95% CI, 0.86 to 2.33]). However, because information on anxiety could not be updated along with CHD risk factor status, the independent association of phobic anxiety in these models is probably underestimated in these updated models. In contrast to the relationships observed above for fatal events, the Crown-Crisp index was not significantly related to nonfatal MI in the age-adjusted model or in the multivariable model that did not include potential biological mediators (Table 2). However, after control for diabetes, hypertension, and hypercholesterolemia, a trend toward a decreased risk over the 4 categories of the Crown-Crisp index emerged (P 0.07). If we updated these and other CHD risk factors over the course of the 12 years of follow-up, this trend became significant (P, trend 0.03; RR comparing extreme categories 0.86 [95% CI, 0.73 to 1.02]). For both fatal CHD and SCD, the elevation in risk appeared to be primarily among women who scored 4 or greater on the phobia index; however, no significant deviations from linearity in the log relative risks were detected in
4 Albert et al Phobic Anxiety and Risk of CHD and SCD in Women 483 TABLE 2. Relative Risks (RR and 95% CI) of CHD in a Cohort of Women Free of CVD at Baseline Followed Up From 1988 to 2000, According to Score on the Crown-Crisp Index Crown-Crisp Index Score 0, P for trend SCD No. of cases Person-years Age-adjusted ( ) 1.18 ( ) 1.77 ( ) Multivariate I* ( ) 1.14 ( ) 1.59 ( ) 0.03 Multivariate ( ) 1.08 ( ) 1.45 ( ) 0.06 Fatal CHD No. of cases Person-years Age-adjusted ( ) 0.99 ( ) 1.55 ( ) Multivariate I* ( ) 0.92 ( ) 1.31 ( ) 0.02 Multivariate ( ) 0.88 ( ) 1.18 ( ) 0.12 Nonfatal MI No. of cases Person-years Age-adjusted ( ) 1.04 ( ) 1.08 ( ) 0.56 Multivariate I* ( ) 0.97 ( ) 0.95 ( ) 0.32 Multivariate ( ) 0.94 ( ) 0.89 ( ) 0.07 *Adjusted for age, smoking status (never, past, current 1 24, 15 24, 25 cigarettes/d), body mass index ( 25, , 30 kg/m 2 ), alcohol intake (0, 5, 5 14, 15 g/d), menopausal status and postmenopausal hormone use (current, past, never), parental history of myocardial infarction before age 60 years (yes vs no), vigorous to moderate activity ( 2, 2 3.9, 4 h/wk), usual aspirin use ( 1/wk, 1 6/wk, and 7 /wk), and valium use ( 1/wk, 1/wk). Adjusted for factors cited above and history of hypertension (yes vs no), hypercholesterolemia (yes vs no), and diabetes (yes vs no). any of the models. In secondary post hoc analyses, we compared women who scored 4 or greater with those who scored less than 4 on the phobia index (Table 3). Women who scored 4 or greater were at a 1.52-fold (95% CI, 1.01 to 2.30; P 0.04) increased risk of SCD and a 1.30-fold (95% CI, 1.02 to 1.67; P 0.04) increased risk of fatal CHD even after adjustment for all of the above covariates. Again, a trend toward a lower risk for nonfatal MI was observed in the women who scored 4 or above. We then explored whether risk varied over the follow-up period by examining the interaction between the logarithm of time and the Crown-Crisp index in the multivariable models. This interaction was of borderline significance for SCD (P 0.06) but did not approach significance for either nonfatal MI or fatal CHD. For SCD, the hazard ratio for the interaction term was positive (1.07; 95% CI, 1.00 to 1.15), indicating that risk may have been higher during the later follow-up period. Figure 2 displays the age-adjusted risk for SCD associated with the Crown-Crisp index by 4-year time periods. In these secondary post hoc analyses, the elevation in risk appeared to be confined primarily to the last 4 years of follow-up, when the majority (52%) of the SCDs occurred (multivariable P, trend 0.004). We then explored whether an interaction with age could explain this varying effect, and there was no evidence for an interaction with age for any of the outcomes. Finally, we examined the age-adjusted associations of the individual items on the phobia scale (Table 4). Four individual items were associated with an elevation in the risk of SCD and fatal CHD: having an unreasonable fear of being in enclosed spaces, feeling panicky in crowds, feeling more relaxed indoors, and feeling uneasy traveling on buses or trains. The first symptom is characteristic of claustrophobia, whereas the latter 3 questions represent typical features of agoraphobia. These 4 items appeared to be more predictive of risk compared with other phobias pertaining to incurable illnesses, relative s safety, or fear of heights (acrophobia). As observed for the composite score, none of the individual items were associated with nonfatal MI (data not shown). Discussion In this large, prospective cohort study of women who were free of reported CVD at baseline, phobic anxiety, as measured by the Crown-Crisp index, was associated with an increase in risk of SCD and fatal CHD but not of nonfatal MI in age-adjusted and multivariable models that excluded potential biological mediators. In these multivariable models, women who scored 4 or greater on the Crown-Crisp index
5 484 Circulation February 1, 2005 TABLE 3. Relative Risks (RR and 95% CI) of CHD From 1988 to 2000 According to Score on the Crown-Crisp Index of >4 Crown-Crisp Index Score 4 4 P SCD No. of cases Age-adjusted ( ) Multivariate I* ( ) 0.02 Multivariate ( ) 0.04 Fatal CHD No. of cases Age-adjusted ( ) Multivariate I* ( ) Multivariate ( ) 0.04 Nonfatal MI No. of cases Age-adjusted ( ) 0.73 Multivariate I* ( ) 0.28 Multivariate ( ) 0.07 *Adjusted for age, smoking status (never, past, current 1 24, 15 24, 25 cigarettes/d), body mass index ( 25, , 30 kg/m 2 ), alcohol intake (0, 5, 5 14, 15 g/d), menopausal status and postmenopausal hormone use (current, past, never), parental history of myocardial infarction before age 60 years (yes vs no), vigorous to moderate activity ( 2, 2 3.9, 4 h/wk), usual aspirin use ( 1/wk, 1 6/wk, and 7 /wk), and valium use ( 1/wk, 1/wk). Adjusted for factors cited above and history of hypertension (yes vs no), hypercholesterolemia (yes vs no), and diabetes (yes vs no). were at a 1.59-fold (95% CI, 0.97 to 2.60) increased risk of SCD and a 1.31-fold (95% CI, 0.97 to 1.75) increased risk of fatal CHD compared with those who scored 0 or 1. After control for these possible intermediaries (hypertension, diabetes, and elevated cholesterol), a trend toward an increased risk persisted only for SCD (P 0.06), indicating that at least part of the observed elevation in risk, particularly for fatal CHD, can be accounted for by these CHD risk factors. In contrast, there was no relationship between phobic anxiety and nonfatal MI in either age-adjusted or multivariable models that excluded potential mediators in the causal pathway, whereas a trend toward a lower risk emerged in multivariable models that controlled for possible mediators (P 0.07). For SCD and fatal CHD, the risk appeared to increase in the fourth quartile, which corresponded to a score of 4 or higher on the phobia index; however, no significant deviations from linearity in the log relative risks were detected in any of the models. Because only 9% of the population scored higher than 4 on the index (Figure 1), we were limited in our ability to determine whether this elevation represented a threshold or whether the risk increased further with higher scores on the index. In secondary post hoc analyses, a score of 4 or greater was associated with a 52% increased risk of SCD and a 30% increased risk of fatal CHD compared with women who scored lower than 4 on the phobia index. Both elevations in risk remained significant even after control for multiple CHD risk factors, including those potentially in the causal pathway. These data are generally consistent with those previously reported on the effect of chronic phobic anxiety on CHD in 3 prospective male cohorts. 4 6 All of these studies reported positive associations with fatal CHD end points and no relationship with nonfatal CHD. The British Northwick Park Heart Study, 4 which included 1457 Caucasian men followed up for 6 years, first reported a significant association between scores on the Crown-Crisp index and fatal CHD. Men who were in the approximate top quartile (score of 5 or greater) had a relative risk of 3.8 (95% CI, 1.6 to 8.6) of fatal CHD. The US Health Professionals Follow-up Study of men confirmed and expanded on these results by specifically examining SCD. 5 Over 2 years of follow-up, high levels of phobic anxiety on the Crown-Crisp index (score of 4 or greater) were associated with a 2.5-fold increase in risk of CHD death, which was entirely because of a 6-fold increase in SCD. The magnitudes of the relative risk elevations in these 2 studies were higher than in the present study; however, the numbers of fatal CHD events (n 40 to 57) and Figure 2. Age-adjusted relative risk of SCD according to scores on Crown- Crisp index by 4-year follow-up periods.
6 Albert et al Phobic Anxiety and Risk of CHD and SCD in Women 485 TABLE 4. Age-Adjusted Relative Risks (RR and 95% CI) of SCD and Fatal CHD From 1988 to 2000 According to Answers to Individual Questions on the Crown-Crisp Index SCD Fatal CHD Do you have an unreasonable fear of being in enclosed spaces such as shops, lifts, etc? Never Sometimes 1.79 ( ) 1.80 ( ) Often 2.22 ( ) 2.51 ( ) Do you find yourself worrying about getting some incurable illness? Never Sometimes 0.92 ( ) 0.95 ( ) Often 0.56 ( ) 1.49 ( ) Are you scared of heights? Not at all Moderately 0.93 ( ) 0.89 ( ) Very 1.22 ( ) 1.33 ( ) Do you feel panicky in crowds? Not at all Moderately 1.51 ( ) 1.22 ( ) Very 2.22 ( ) 3.43 ( ) Do you worry unduly when relatives are late in coming home? No Yes 1.06 ( ) 1.08 ( ) Do you feel more relaxed indoors? Not particularly Sometimes 1.32 ( ) 1.92 ( ) Definitely 3.90 ( ) 2.40 ( ) Do you dislike going out alone? No Yes 1.33 ( ) 1.54 ( ) Do you feel uneasy traveling on buses or trains even if they are not crowded? Not at all A little 1.03 ( ) 1.41 ( ) Definitely 2.91 ( ) 3.44 ( ) SCDs (n 16) were much lower, leading to less stable estimates of risk. The Normative Aging Study also found similar results over a longer follow-up period (up to 28 years) by use of another measure of chronic anxiety found to correlate with the Crown-Crisp index. 6 The differential association with fatal CHD, particularly SCD, versus nonfatal CHD end points in this and previous studies suggests that phobic anxiety may influence cardiovascular risk to a greater extent through direct effects on arrhythmogenesis and fatal ventricular arrhythmias 14 than through effects on atherogenesis 15 and/or thrombosis. Conversion of nonfatal ischemic events to fatal arrhythmic events through proarrhythmic mechanisms associated with chronic phobic anxiety 14 might explain the seemingly paradoxical lower risk of nonfatal MI in the fully controlled multivariable model. A similar phenomenon was reported in the CAST 1 trial, in which the treatment group had a significantly lower nonfatal CHD event rate despite having a higher mortality and SCD rate because of proarrhythmic effects of the IC antiarrhythmic drugs tested. 16 Possible proarrhythmic mechanisms associated with anxiety include alterations in autonomic tone manifested by decreased vagal and increased sympathetic components, thereby increasing the overall susceptibility to ventricular fibrillation. Individuals with high levels of anxiety have reduced heart rate variability compared with normal subjects, 17 which has been shown to predict SCD in the elderly 18 and in patients with heart failure. 19 Also, acute attacks of anxiety or mental stress may trigger episodes of fatal ventricular arrhythmias in susceptible patients. It is well documented that acute increases in the incidence of SCD can occur in populations suffering acute psychological stressors such as
7 486 Circulation February 1, 2005 earthquakes or wars. 20 Potential mechanisms include increases in sympathetic nervous system activity, leading to cardiac instability 21 and an acute increase in susceptibility to ventricular fibrillation and SCD. When we examined the associations between phobic anxiety and risk of CHD over time, only the association with SCD risk appeared to vary by time. The elevation in risk appeared to emerge in the last 4 years of the study, suggesting that the chronic rather than acute effects of anxiety on cardiac electrophysiology may be of greater importance. Alternatively, the increasing association over time might be a consequence of the higher number of events that occurred at the end of the study and the resulting greater power to detect an association. The temporal relationship found for SCD in our study differs from that reported for fatal CHD among men in the Northwick Park Heart Study, in which the association between the Crown-Crisp index and fatal CHD was found to diminish with increasing length of follow-up. 22 Also, in the Health Professionals Follow-up Study, the elevation in SCD risk was found after only 2 years of follow-up. 5 In addition to direct effects on myocardial vulnerability, anxiety may also lead to diabetes, hypertension, and hypercholesterolemia. Chronically elevated catecholamine levels have been shown to increase lipoprotein lipase levels, 23 induce hyperglycemia, 24 and elevate blood pressure. 25 Because these disease states might, at least in part, be biological mediators in the causal pathway of CHD, analyses were performed excluding these variables from the model (multivariable model 1). In these models, the relationship with SCD and fatal CHD remained significant over the 4 categories of the Crown-Crisp index. Control for these potential intermediaries appeared to have a greater impact on the risk estimates for fatal CHD and nonfatal MI than for SCD, suggesting that these mechanisms may be more important in the causal pathway for these end points. In support of this concept, when data on CHD risk factors were updated over time, the relationship with fatal CHD was almost completely attenuated and the trend for SCD persisted. The lower prevalence of CHD among women who suffer SCD found in autopsy and cardiac arrest survivor series may provide a potential explanation for this finding. 26 Finally, symptoms of phobic anxiety may lead to unhealthy lifestyle habits, such as smoking and physical inactivity, which in turn increase the risk of CHD. If such behaviors lie in the causal pathway between anxiety and CHD, then treating them as confounding variables, as was done in the multivariable analyses, might underestimate the overall impact of phobic anxiety on CHD risk. 27 There are several limitations of the present study. As described above, phobic anxiety was directly related to several CHD risk factors, and residual confounding by these risk factors could account for at least part of the association between phobic anxiety and SCD and fatal CHD. Also, phobic anxiety might affect adherence to medical therapies, which could not be controlled for in this analysis. However, if confounding by CHD risk factors and/or medical adherence accounted for all of the association, one would also expect to have observed a positive association between phobic anxiety and nonfatal MI. Another important limitation of the study is the single measure of phobic anxiety, and therefore, the inability to account for changes in phobic anxiety over time, which would tend to obscure associations if the effect is of short duration. However, the score on the Crown-Crisp index was significantly associated with benzodiazepine use 12 years later, supporting the concept that phobic disorders tend to be chronic in nature. 28 Also, we did not find any evidence that associations diminished with increasing length of followup. In contrast, the association appeared to increase for SCD. Finally, this was a relatively healthy population of predominately Caucasian female registered nurses (approximately 96%) who were free of CVD and cancer at study entry, with a relatively low CHD event rate. Therefore, it is unclear whether these results would be generalizable to non- Caucasian or other less healthy populations. However, despite the selective nature of the cohort, we believe that these data represent an important addition to the previous published studies in men, especially given the higher prevalence of phobic and/or anxiety disorders in women. In summary, these prospective data suggest that higher levels of phobic anxiety are associated with an increased risk of fatal CHD, particularly from SCD, but not nonfatal MI. Some but not all of this risk can be accounted for by CHD risk factors and lifestyle factors associated with phobic anxiety. If phobic and/or anxiety disorders increase the risk for SCD in women, then the public health importance of such a finding could be quite substantial. In one general population sample, the prevalence estimates for agoraphobia, simple phobia, and social phobia were 9.0%, 15.7%, and 16.5%, respectively, among women, and rates were twice as high as among men. 8 Prevalence estimates for generalized anxiety disorder are approximately 5% in the general population, and again, the prevalence is estimated to be 2 to 3 times higher in women than in men. 7 Attention and resources directed at the recognition, diagnosis, and treatment of these disorders could potentially reduce SCD incidence in otherwise healthy populations. Acknowledgments This study was supported by the Charles A. Dana Foundation s Brain-Body Invitational Award and by grants HL and CA from the National Institutes of Health. We are indebted to the participants in the Nurses Health Study for their outstanding commitment and cooperation and to Lisa Dunn, Barbara Egan, Karen Corsano, and Gary Chase for their expert and unfailing assistance. We are also indebted to Rimma Dushkes for her technical assistance in preparing the manuscript. References 1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99: Kubzansky LD, Kawachi I. Going to the heart of the matter: negative emotions and coronary heart disease. J Psychosom Res. 2000;48: Coryell W, Noyes R, Hause JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 1986;143: Haines AP, Imeson JD, Meade TW. Phobic anxiety and ischaemic heart disease. BMJ. 1987;295: Kawachi I, Colditz GA, Ascherio A, Rimm Eric B, Giovannucci E, Stampfer MJ, Willett WC. Coronary heart disease/myocardial infarction: prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 1994;89:
8 Albert et al Phobic Anxiety and Risk of CHD and SCD in Women Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Coronary heart disease/ myocardial infarction: symptoms of anxiety and risk of coronary heart disease: the Normative Aging Study. Circulation. 1994;90: Wittchen HU, Zhao S, Kessler RC, Eaton WW. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51: Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996;53: Crown S, Crisp AH. A short clinical diagnostic self-rating scale for psychoneurotic patients: the Middlesex Hospital questionnaire. Br J Psychiatry. 1956;112: Burgess PM, Mazzocco L, Campbell IM. Discriminant validity of the Crown-Crisp experimental index. Br J Psychiatry. 1987;60: Rose GA, Blackburn H. Cardiovascular Survey Methods. WHO Monograph Series No. 58. Geneva, Switzerland: World Health Organization; Albert CM, Chae CU, Grodstein F, Rose LM, Rexrode KM, Ruskin JN, Stampfer MJ, Manson JE. Prospective study of sudden cardiac death among women in the United States. Circulation. 2003;107: Hinkle L, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65: Lown B, Verrier RL, Corbalan R. Psychological stress and threshold for repetitive ventricular response. Science. 1973;182: O Malley PG, Jones DL, Feuerstein IM, Taylor AJ. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med. 2000;343: Greenberg HM, Dwyer EM, Hochman JS, Steinberg JS, Echt DS, Peters RW. Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST1. Br Heart J. 1995;74: Kawachi I, Sparrow D, Vokonas PS, Weiss ST. Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol. 1995;75: La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107: Makikallio TH, Huikuri HV, Makikallio A, Sourander LB, Mitrani RD, Castellanos A, Myerburg RJ. Prediction of sudden cardiac death by fractal analysis of heart rate variability in elderly subjects. J Am Coll Cardiol. 2001;37: Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334: Kop WJ, Krantz DS, Nearing BD, Gottdiener JS, Quigley JF, O Callahan M, DelNegro AA, Friehling TD, Karasik P, Suchday S, Levine J, Verrier RL. Effects of acute mental stress and exercise on T-wave alternans in patients with implantable cardioverter defibrillators and controls. Circulation. 2004;109: Haines A, Cooper J, Meade TW. Psychological characteristics and fatal ischaemic heart disease. Heart. 2001;85: Hayward C, Taylor CB, Roth WT, King R, Agras WS. Plasma lipid levels in patients with panic disorder or agoraphobia. Am J Psychiatry. 1992; 142: Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, Lustman PJ. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32: Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Family Med. 1997;6: Albert CM, McGovern BA, Newell JB, Ruskin JN. Sex differences in cardiac arrest survivors. Circulation. 1996;93: Hemingway H, Marmot M. Psychosocial factors in the aetiology and prognosis of coronary heart disease: systematic review of prospective cohort studies. BMJ. 1999;318: Robins LN, Locke BZ, Regier DA. Overview: psychiatric disorders in America. In: Robins LN, Regier DA (eds). Psychiatric Disorders in America. New York, NY: Free Press; 1991:
The Impact of Diabetes Mellitus and Prior Myocardial Infarction on Mortality From All Causes and From Coronary Heart Disease in Men
Journal of the American College of Cardiology Vol. 40, No. 5, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)02044-2
More informationElevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Elevated Risk of Cardiovascular Disease Prior to Clinical Diagnosis of Type 2 Diabetes FRANK B. HU, MD 1,2,3 MEIR J. STAMPFER,
More informationORIGINAL INVESTIGATION. Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease
ORIGINAL INVESTIGATION Alcohol Consumption and Mortality in Men With Preexisting Cerebrovascular Disease Vicki A. Jackson, MD; Howard D. Sesso, ScD; Julie E. Buring, ScD; J. Michael Gaziano, MD Background:
More informationEpidemiological studies indicate that a parental or family
Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women Howard D. Sesso, ScD, MPH; I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD, MPH; Kathryn M. Rexrode,
More informationFolate, vitamin B 6, and vitamin B 12 are cofactors in
Research Letters Dietary Folate and Vitamin B 6 and B 12 Intake in Relation to Mortality From Cardiovascular Diseases Japan Collaborative Cohort Study Renzhe Cui, MD; Hiroyasu Iso, MD; Chigusa Date, MD;
More informationSudden cardiac death (SCD) is a leading cause of cardiovascular
Smoking, Smoking Cessation, and Risk of Sudden Cardiac Death in Women Roopinder K. Sandhu, MD, MPH; Monik C. Jimenez, ScD; Stephanie E. Chiuve, ScD; Kathryn C. Fitzgerald, MSc; Stacey A. Kenfield, ScD;
More informationNIH Public Access Author Manuscript Am Heart J. Author manuscript; available in PMC 2010 November 1.
NIH Public Access Author Manuscript Published in final edited form as: Am Heart J. 2009 November ; 158(5): 761 767. doi:10.1016/j.ahj.2009.08.015. Intake of total trans, trans-18:1 and trans-18:2 fatty
More informationDietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women
07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.
More informationSetting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA.
Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project
More informationORIGINAL INVESTIGATION. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women
The Impact of Mellitus on Mortality From All Causes and Coronary Heart Disease in Women 20 Years of Follow-up ORIGINAL INVESTIGATION Frank B. Hu, MD; Meir J. Stampfer, MD; Caren G. Solomon, MD; Simin Liu,
More informationI t is established that regular light to moderate drinking is
32 CARDIOVASCULAR MEDICINE Taking up regular drinking in middle age: effect on major coronary heart disease events and mortality S G Wannamethee, A G Shaper... See end of article for authors affiliations...
More informationWhole-grain consumption and risk of coronary heart disease: results from the Nurses Health Study 1 3
Whole-grain consumption and risk of coronary heart disease: results from the Nurses Health Study 1 3 Simin Liu, Meir J Stampfer, Frank B Hu, Edward Giovannucci, Eric Rimm, JoAnn E Manson, Charles H Hennekens,
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1997, by the Massachusetts Medical Society VOLUME 336 J UNE 19, 1997 NUMBER 25 POSTMENOPAUSAL HORMONE THERAPY AND MORTALITY FRANCINE GRODSTEIN, SC.D., MEIR
More informationThe New England Journal of Medicine PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE. Population
PRIMARY PREVENTION OF CORONARY HEART DISEASE IN WOMEN THROUGH DIET AND LIFESTYLE MEIR J. STAMPFER, M.D., FRANK B. HU, M.D., JOANN E. MANSON, M.D., ERIC B. RIMM, SC.D., AND WALTER C. WILLETT, M.D. ABSTRACT
More informationSmoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus
ORIGINAL INVESTIGATION Smoking and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus Wael K. Al-Delaimy, MD, PhD; JoAnn E. Manson, MD, DrPH; Caren G. Solomon, MD, MPH; Ichiro Kawachi,
More informationThe long-chain n-3 fatty acids found in fish have been
Dietary -Linolenic Acid Intake and Risk of Sudden Cardiac Death and Coronary Heart Disease Christine M. Albert, MD; Kyungwon Oh, PhD; William Whang, MD; JoAnn E. Manson, MD; Claudia U. Chae, MD; Meir J.
More informationSeveral studies have reported that people with periodontal
Oral Health and Peripheral Arterial Disease Hsin-Chia Hung, DDS, DrPH; Walter Willett, MD, DrPH; Anwar Merchant, DMD, DrPH; Bernard A. Rosner, PhD; Alberto Ascherio, MD, DrPH; Kaumudi J. Joshipura, ScD
More informationSupplementary Online Content
Supplementary Online Content Li S, Chiuve SE, Flint A, et al. Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med. Published online September 2, 2013. doi:10.1001/jamainternmed.2013.9768.
More informationDiabetes Care Publish Ahead of Print, published online February 25, 2010
Diabetes Care Publish Ahead of Print, published online February 25, 2010 Undertreatment Of Mental Health Problems In Diabetes Undertreatment Of Mental Health Problems In Adults With Diagnosed Diabetes
More informationORIGINAL INVESTIGATION. Self-Selected Posttrial Aspirin Use and Subsequent Cardiovascular Disease and Mortality in the Physicians Health Study
ORIGINAL INVESTIGATION Self-Selected Posttrial Aspirin Use and Subsequent Cardiovascular Disease and Mortality in the Physicians Health Study Nancy R. Cook, ScD; Patricia R. Hebert, PhD; JoAnn E. Manson,
More informationMeasures of Obesity and Cardiovascular Risk Among Men and Women
Journal of the American College of Cardiology Vol. 52, No. 8, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.03.066
More informationALTHOUGH STROKE-RELATED
ORIGINAL CONTRIBUTION Whole Grain Consumption and Risk of Ischemic Stroke in Women A Prospective Study Simin Liu, MD, ScD JoAnn E. Manson, MD, DrPH Meir J. Stampfer, MD, DrPH Kathryn M. Rexrode, MD Frank
More informationRotating night shift work and risk of psoriasis in US women
Rotating night shift work and risk of psoriasis in US women The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Published
More informationORIGINAL INVESTIGATION. Depression Is a Risk Factor for Coronary Artery Disease in Men
Depression Is a Risk Factor for Coronary Artery Disease in Men The Precursors Study ORIGINAL INVESTIGATION Daniel E. Ford, MD, MPH; Lucy A. Mead, ScM; Patricia P. Chang, MD; Lisa Cooper-Patrick, MD, MPH;
More informationAlthough the association between blood pressure and
Two-Year Changes in Blood Pressure and Subsequent Risk of Cardiovascular Disease in Men Howard D. Sesso, ScD, MPH; Meir J. Stampfer, MD, DrPH; Bernard Rosner, PhD; J. Michael Gaziano, MD, MPH; Charles
More informationNIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2014 June 24.
NIH Public Access Author Manuscript Published in final edited form as: JAMA Intern Med. 2013 June 24; 173(12): 1150 1151. doi:10.1001/jamainternmed.2013.910. SSRI Use, Depression and Long-Term Outcomes
More informationLong-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease
Long-term prognostic value of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) changes within one year in patients with coronary heart disease D. Dallmeier 1, D. Rothenbacher 2, W. Koenig 1, H. Brenner
More informationRheumatoid arthritis (RA) is the most common systemic
Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Daniel H. Solomon, MD, MPH; Elizabeth W. Karlson, MD; Eric B. Rimm, ScD; Carolyn C. Cannuscio, ScD; Lisa A. Mandl, MD, MPH; JoAnn
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationAnxiety Worsens Prognosis in Patients With Coronary Artery Disease
Journal of the American College of Cardiology Vol. 49, No. 20, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.03.007
More informationThe role of long-chain -3 fatty acids in the management
Clinical Investigation and Reports Fish and Long-Chain -3 Fatty Acid Intake and Risk of Coronary Heart Disease and Total Mortality in Diabetic Women Frank B. Hu, MD; Eunyoung Cho, ScD; Kathryn M. Rexrode,
More informationFruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2
Fruit and vegetable intake and risk of cardiovascular disease: the Women s Health Study 1,2 Simin Liu, JoAnn E Manson, I-Min Lee, Stephen R Cole, Charles H Hennekens, Walter C Willett, and Julie E Buring
More informationRisk Factors for Mortality in the Nurses Health Study: A Competing Risks Analysis
American Journal of Epidemiology ª The Author 2010. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail:
More informationYOUNG ADULT MEN AND MIDDLEaged
BRIEF REPORT Favorable Cardiovascular Profile in Young Women and Long-term of Cardiovascular and All-Cause Mortality Martha L. Daviglus, MD, PhD Jeremiah Stamler, MD Amber Pirzada, MD Lijing L. Yan, PhD,
More informationPapers. Abstract. Subjects and methods. Introduction
Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study Frank B Hu, Meir J Stampfer, JoAnn E Manson, Eric B Rimm, Graham A Colditz, Bernard A Rosner, Frank E Speizer,
More informationO besity is associated with increased risk of coronary
134 RESEARCH REPORT Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes S Goya Wannamethee, A Gerald Shaper, Mary Walker... See end of article for
More informationHeart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial
Heart Rate in Patients with Coronary Artery Disease - the Lower the Better? An Analysis from the Treating to New Targets (TNT) trial Sripal Bangalore, MD, MHA, Chuan-Chuan Wun, PhD, David A DeMicco, PharmD,
More informationThe Whitehall II study originally comprised 10,308 (3413 women) individuals who, at
Supplementary notes on Methods The study originally comprised 10,308 (3413 women) individuals who, at recruitment in 1985/8, were London-based government employees (civil servants) aged 35 to 55 years.
More informationSupplementary Online Content
Supplementary Online Content Åsvold BO, Vatten LJ, Bjøro T, et al; Thyroid Studies Collaboration. Thyroid function within the normal range and risk of coronary heart disease: an individual participant
More informationJSC «Astana Medical University» PhD THESIS ANNOTATION. Specialty: 6D «MEDICINE»
JSC «Astana Medical University» PhD THESIS ANNOTATION Specialty: 6D110100 «MEDICINE» Title: «Prognostic efficiency of sudden cardiac death s predictors in preserved and moderately reduced left ventricle
More informationBaldness and Coronary Heart Disease Rates in Men from the Framingham Study
A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart
More informationCigarette Smoking and Incidence of Chronic Bronchitis and Asthma in Women*
Cigarette Smoking and ncidence of Chronic Bronchitis and Asthma in Women* Rebecca]. Troisi, SeD; Frank E. Speizer, MD, FCCP; Bernard Rosner, PhD; Dimitrios Trichopoulos, MD; and Walter C. Willett, MD Study
More informationThe Mediterranean Diet: The Optimal Diet for Cardiovascular Health
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International
More informationAutonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors
Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors Carmine Pizzi 1 ; Lamberto Manzoli 2, Stefano Mancini 3 ; Gigliola Bedetti
More informationOverview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health
More informationThe Framingham Coronary Heart Disease Risk Score
Plasma Concentration of C-Reactive Protein and the Calculated Framingham Coronary Heart Disease Risk Score Michelle A. Albert, MD, MPH; Robert J. Glynn, PhD; Paul M Ridker, MD, MPH Background Although
More informationPAPER Abdominal and total adiposity and risk of coronary heart disease in men
(2001) 25, 1047±1056 ß 2001 Nature Publishing Group All rights reserved 0307±0565/01 $15.00 www.nature.com/ijo PAPER Abdominal and total adiposity and risk of coronary heart disease in men KM Rexrode 1
More informationARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal # 1475 PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Hypertension, left ventricular hypertrophy, and risk of incident hospitalized
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationAbundant evidence has accumulated supporting the association
Folate, Vitamin B 6, and B 12 Intakes in Relation to Risk of Stroke Among Men Ka He, MD; Anwar Merchant, DMD; Eric B. Rimm, ScD; Bernard A. Rosner, PhD; Meir J. Stampfer, MD; Walter C. Willett, MD; Alberto
More informationThe Framingham Risk Score (FRS) is widely recommended
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany Wolfgang Koenig, MD; Hannelore
More informationDietary intake of -linolenic acid and risk of fatal ischemic heart disease among women 1 3
Dietary intake of -linolenic acid and risk of fatal ischemic heart disease among women 1 3 Frank B Hu, Meir J Stampfer, JoAnn E Manson, Eric B Rimm, Alicja Wolk, Graham A Colditz, Charles H Hennekens,
More informationStroke is the third leading cause of death in the United
Original Contributions Prospective Study of Major Dietary Patterns and Stroke Risk in Women Teresa T. Fung, ScD; Meir J. Stampfer, MD, DPH; JoAnn E. Manson, MD, DPH; Kathryn M. Rexrode, MD; Walter C. Willett,
More informationThe Gender Divide Women, Men and Heart Disease February 2017
The Gender Divide Women, Men and Heart Disease February 2017 Nandita S. Scott, MD FACC Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital Heart Disease For
More informationSaturated fat- how long can you go/how low should you go?
Saturated fat- how long can you go/how low should you go? Peter Clifton Baker IDI Heart and Diabetes Institute Page 1: Baker IDI Page 2: Baker IDI Page 3: Baker IDI FIGURE 1. Predicted changes ({Delta})
More informationREVIEW ARTICLE. Prolonged QTc Interval and Risks of Total and Cardiovascular Mortality and Sudden Death in the General Population
REVIEW ARTICLE Prolonged QTc Interval and Risks of Total and Cardiovascular and Sudden Death in the General Population A Review and Qualitative Overview of the Prospective Cohort Studies Alicia Montanez,
More informationn 3 FATTY ACIDS AND SUDDEN DEATH BLOOD LEVELS OF LONG-CHAIN n 3 FATTY ACIDS AND THE RISK OF SUDDEN DEATH
n 3 FATTY ACIDS AND SUDDEN DEATH BLOOD LEVELS OF LONG-CHAIN n 3 FATTY ACIDS AND THE RISK OF SUDDEN DEATH CHRISTINE M. ALBERT, M.D., M.P.H., HANNIA CAMPOS, PH.D., MEIR J. STAMPFER, M.D., DR.P.H., PAUL M.
More informationExercise treadmill testing is frequently used in clinical practice to
Preventive Cardiology FEATURE Case Report 55 Commentary 59 Exercise capacity on treadmill predicts future cardiac events Pamela N. Peterson, MD, MSPH 1-3 David J. Magid, MD, MPH 3 P. Michael Ho, MD, PhD
More informationDefibrillation testing should be routinely performed at the time of implantable cardioverter-defibrillator implantation Contra
Defibrillation testing should be routinely performed at the time of implantable cardioverter-defibrillator implantation Contra Fernando Arribas Cardiology Service Hospital 12 de Octubre Madrid Spain D.O.I.
More informationA nationwide population-based study. Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD
The Association of Clinical Symptomatic Hypoglycemia with Cardiovascular Events and Total Death in Type 2 Diabetes Mellitus A nationwide population-based study Pai-Feng Hsu M.D. Shao-Yuan Chuang PhD Taipei
More informationLecture 8 Cardiovascular Health Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors
Lecture 8 Cardiovascular Health 1 Lecture 8 1. Introduction 2. Cardiovascular Health 3. Stroke 4. Contributing Factors 1 Human Health: What s Killing Us? Health in America Health is the U.S Average life
More informationDepressive Symptoms and Risk of Type 2 Diabetes in Women
Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E Depressive Symptoms and Risk of Type 2 Diabetes in Women CASSANDRA ARROYO, MS, PHD 1 FRANK B. HU, MD, PHD 2,6 LOUISE M.
More informationI t is well established that non-insulin dependent diabetes is
1398 CARDIOVASCULAR MEDICINE Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease S G Wannamethee, A G Shaper, L Lennon... See end of article
More informationKathryn M. Rexrode, MD, MPH. Assistant Professor. Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School
Update: Hormones and Cardiovascular Disease in Women Kathryn M. Rexrode, MD, MPH Assistant Professor Division of Preventive Medicine Brigham and Women s s Hospital Harvard Medical School Overview Review
More informationThe TNT Trial Is It Time to Shift Our Goals in Clinical
The TNT Trial Is It Time to Shift Our Goals in Clinical Angioplasty Summit Luncheon Symposium Korea Assoc Prof David Colquhoun 29 April 2005 University of Queensland, Wesley Hospital, Brisbane, Australia
More informationCardiovascular Diseases and Diabetes
Cardiovascular Diseases and Diabetes LEARNING OBJECTIVES Ø Identify the components of the cardiovascular system and the various types of cardiovascular disease Ø Discuss ways of promoting cardiovascular
More informationDietary Fat and Coronary Heart Disease: A Comparison of Approaches for Adjusting for Total Energy Intake and Modeling Repeated Dietary Measurements
American Journal of Epidemiology Copyright 1999 by The Johns Hopkins University School of Hygiene and Public Health Aii ilgltis reserved Vol.149, No. 6 Printed In USA. Dietary Fat and Coronary Heart Disease:
More informationCurrent Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes
Current Use of Unopposed Estrogen and Estrogen Plus Progestin and the Risk of Acute Myocardial Infarction Among Women With Diabetes The Northern California Kaiser Permanente Diabetes Registry, 1995 1998
More informationAntioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 3
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts 1 3 Paul Knekt, John Ritz, Mark A Pereira, Eilis J O Reilly, Katarina Augustsson, Gary E Fraser, Uri Goldbourt, Berit
More informationT here is a rapid increase of people reporting feelings of
794 RESEARCH REPORT Is perceived nervousness and anxiety a predictor of premature mortality and severe morbidity? A longitudinal follow up of the Swedish survey of living conditions Gunilla Ringbäck Weitoft,
More informationCopyright, 1995, by the Massachusetts Medical Society
Copyright, 1995, by the Massachusetts Medical Society Volume 332 MAY 11, 1995 Number 19 ALCOHOL CONSUMPTION AND MORTALITY AMONG WOMEN CHARLES S. FUCHS, M.D., MEIR J. STAMPFER, M.D., GRAHAM A. COLDITZ,
More informationChest pain and subsequent consultation for coronary heart disease:
Chest pain and subsequent consultation for coronary heart disease: a prospective cohort study Peter R Croft and Elaine Thomas ABSTRACT Background Chest pain may not be reported to general practice but
More informationA lthough the hazards of smoking are well described,
702 RESEARCH REPORT Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart
More informationAndrew J. Dimond, David S. Krantz, Andrew J. Waters, Romano Endrighi, Stephen S. Gottlieb
Andrew J. Dimond, David S. Krantz, Andrew J. Waters, Romano Endrighi, Stephen S. Gottlieb Uniformed Services University, Bethesda MD and University of Maryland Hospital, Baltimore MD Heart Failure Serious
More informationOut-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry
European Heart Journal (2003) 24, 1204 1209 Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry Anton P.M. Gorgels*, Claudia Gijsbers, Jacqueline de
More informationSUPPLEMENTAL MATERIALS
SUPPLEMENTAL MATERIALS Table S1: Variables included in the propensity-score matching Table S1.1: Components of the CHA 2DS 2Vasc score Table S2: Crude event rates in the compared AF patient cohorts Table
More informationJournal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.
Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary
More informationDiabetes and the Heart
Diabetes and the Heart Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 6, 2012 Outline Screening for diabetes in patients with CAD Screening for CAD in patients with
More informationINTERNAL VALIDITY, BIAS AND CONFOUNDING
OCW Epidemiology and Biostatistics, 2010 J. Forrester, PhD Tufts University School of Medicine October 6, 2010 INTERNAL VALIDITY, BIAS AND CONFOUNDING Learning objectives for this session: 1) Understand
More informationARIC Manuscript Proposal #1491. PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority:
ARIC Manuscript Proposal #1491 PC Reviewed: 03/17/09 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: The Association of Hemoglobin A1c with Depressive Symptoms in Persons with and
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More informationSupplementary Online Content
Supplementary Online Content Song M, Fung TT, Hu FB, et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med. Published online August 1, 2016.
More informationDiscontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
open access Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database Yana Vinogradova, 1 Carol Coupland, 1 Peter Brindle, 2,3 Julia Hippisley-Cox
More informationDiabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians
Universidade de Sao Paulo From the SelectedWorks of Paulo A Lotufo 2001 Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians Paulo A Lotufo, Universidade de São Paulo JoAnn
More informationFish Consumption and Risk of Sudden Cardiac Death
Original Contributions Fish Consumption and Risk of Sudden Cardiac Death Christine M. Albert, MD; Charles H. Hennekens, MD; Christopher J. O Donnell, MD; Umed A. Ajani, MBBS; Vincent J. Carey, PhD; Walter
More informationAspirin Use and Risk of Atrial Fibrillation in the Physicians' Health Study
Aspirin Use and Risk of Atrial Fibrillation in the Physicians' Health Study The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation
More informationJUPITER NEJM Poll. Panel Discussion: Literature that Should Have an Impact on our Practice: The JUPITER Study
Panel Discussion: Literature that Should Have an Impact on our Practice: The Study Kaiser COAST 11 th Annual Conference Maui, August 2009 Robert Blumberg, MD, FACC Ralph Brindis, MD, MPH, FACC Primary
More informationOVER the past three decades, there has been an effort to
Journal of Gerontology: PSYCHOLOGICAL SCIENCES 2007, Vol. 62B, No. 5, P295 P299 Copyright 2007 by The Gerontological Society of America DSM-IV Personality Disorders and Coronary Heart Disease in Older
More informationPHYSICAL INACTIVITY AND BODY
ORIGINAL CONTRIBUTION Relationship of Physical Activity vs Body Mass Index With Type 2 Diabetes in Women Amy R. Weinstein, MD, MPH Howard D. Sesso, ScD, MPH I. Min Lee, MBBS, ScD Nancy R. Cook, ScD JoAnn
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationAgoraphobia Prepared by Stephanie Gilbert Summary
Agoraphobia Prepared by Stephanie Gilbert Summary The Diagnostic and Statistical Manual of Mental Disorders, IV, cites the criteria for Agoraphobia as with, or without, the occurrence of Panic Disorder.
More informationSUDDEN CARDIAC DEATH (SCD)
ORIGINAL CONTRIBUTION Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women Stephanie E. Chiuve, ScD Teresa T. Fung, ScD Kathryn M. Rexrode, MD, MPH Donna Spiegelman,
More informationPolypharmacy - arrhythmic risks in patients with heart failure
Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012
More informationSweetened beverage consumption and risk of coronary heart disease in women 1 4
Sweetened beverage consumption and risk of coronary heart disease in women 1 4 Teresa T Fung, Vasanti Malik, Kathryn M Rexrode, JoAnn E Manson, Walter C Willett, and Frank B Hu ABSTRACT Background: Previous
More informationThe Immediate Reproducibility of T Wave Alternans During Bicycle Exercise
Reprinted with permission from JOURNAL OF PACING AND CLINICAL ELECTROPHYSIOLOGY, Volume 25, No. 8, August 2002 Copyright 2002 by Futura Publishing Company, Inc., Armonk, NY 10504-0418. The Immediate Reproducibility
More informationHeart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients
ESC Congress 2011 Paris 27-31 August Heart Rate and Cardiac Allograft Vasculopathy in Heart Transplant Recipients M.T. La Rovere, F. Olmetti, G.D. Pinna, R. Maestri, D. Lilleri, A. D Armini, M. Viganò,
More informationDiabetologia 9 Springer-Verlag 1992
Diabetologia (1992) 35:967-972 Diabetologia 9 Springer-Verlag 1992 Oral contraceptive use and the risk of Type 2 (non-insulin-dependent) diabetes mellitus in a large prospective study of women E. B. Rimm,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More information